Cargando…

Palmitoylethanolamide Counteracts Enteric Inflammation and Bowel Motor Dysfunctions in a Mouse Model of Alzheimer’s Disease

Palmitoylethanolamide (PEA), an endogenous lipid mediator, is emerging as a promising pharmacological agent in multiple neurodegenerative disorders for its anti-inflammatory and neuroprotective properties. However, its effects on enteric inflammation and colonic dysmotility associated with Alzheimer...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Antongiovanni, Vanessa, Pellegrini, Carolina, Antonioli, Luca, Benvenuti, Laura, Di Salvo, Clelia, Flori, Lorenzo, Piccarducci, Rebecca, Daniele, Simona, Martelli, Alma, Calderone, Vincenzo, Martini, Claudia, Fornai, Matteo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511319/ https://www.ncbi.nlm.nih.gov/pubmed/34658885 http://dx.doi.org/10.3389/fphar.2021.748021

Ejemplares similares

Dietary Supplement, Containing the Dry Extract of Curcumin, Emblica and Cassia, Counteracts Intestinal Inflammation and Enteric Dysmotility Associated with Obesity
por: D’Antongiovanni, Vanessa, et al.
Publicado: (2023)

The administration of Enterococcus faecium SF68 counteracts compositional shifts in the gut microbiota of diet-induced obese mice
por: Panattoni, Adelaide, et al.
Publicado: (2022)

Prodromal Intestinal Events in Alzheimer’s Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition
por: Pellegrini, Carolina, et al.
Publicado: (2020)

Enteric Glia at the Crossroads between Intestinal Immune System and Epithelial Barrier: Implications for Parkinson Disease
por: Benvenuti, Laura, et al.
Publicado: (2020)

From the intestinal mucosal barrier to the enteric neuromuscular compartment: An integrated overview on the morphological changes in Parkinson’s disease
por: Pellegrini, Carolina, et al.
Publicado: (2021)

The Adenosine System at the Crossroads of Intestinal Inflammation and Neoplasia
por: D’Antongiovanni, Vanessa, et al.
Publicado: (2020)

Managing Obesity and Related Comorbidities: A Potential Pharmacological Target in the Adenosine System?
por: D’Antongiovanni, Vanessa, et al.
Publicado: (2021)

Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology
por: Pellegrini, C., et al.
Publicado: (2022)

Author Correction: Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology
por: Pellegrini, C., et al.
Publicado: (2023)

Intestinal epithelial barrier and neuromuscular compartment in health and disease
por: D’Antongiovanni, Vanessa, et al.
Publicado: (2020)

A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation
por: Pellegrini, Carolina, et al.
Publicado: (2018)

Glial A(2B) Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity
por: D’Antongiovanni, Vanessa, et al.
Publicado: (2020)

Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis
por: D’Antongiovanni, Vanessa, et al.
Publicado: (2022)

Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation
por: Antonioli, Luca, et al.
Publicado: (2021)

Donepezil improves vascular function in a mouse model of Alzheimer’s disease
por: Pellegrini, Carolina, et al.
Publicado: (2021)

A Nutraceutical Strategy to Slowing Down the Progression of Cone Death in an Animal Model of Retinitis Pigmentosa
por: Piano, Ilaria, et al.
Publicado: (2019)

High Levels of β-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse
por: Piccarducci, Rebecca, et al.
Publicado: (2019)

Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide
por: Scuderi, Caterina, et al.
Publicado: (2011)

Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases
por: Pellegrini, Carolina, et al.
Publicado: (2019)

Inflammatory Bowel Diseases: It's Time for the Adenosine System
por: Antonioli, Luca, et al.
Publicado: (2020)

Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity
por: Petrosino, Stefania, et al.
Publicado: (2019)

Influence of Polyphenols on Adipose Tissue: Sirtuins as Pivotal Players in the Browning Process
por: Flori, Lorenzo, et al.
Publicado: (2023)

Palmitoylethanolamide counteracts high-fat diet-induced gut dysfunction by reprogramming microbiota composition and affecting tryptophan metabolism
por: Pirozzi, Claudio, et al.
Publicado: (2023)

Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy
por: Rota, Lucia, et al.
Publicado: (2019)

The Basal Pharmacology of Palmitoylethanolamide
por: Rankin, Linda, et al.
Publicado: (2020)

Involvement of the P2X7 Purinergic Receptor in Colonic Motor Dysfunction Associated with Bowel Inflammation in Rats
por: Antonioli, Luca, et al.
Publicado: (2014)

HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia
por: Sarnelli, Giovanni, et al.
Publicado: (2018)

Delay of Morphine Tolerance by Palmitoylethanolamide
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2015)

NKG2A and COVID-19: another brick in the wall
por: Antonioli, Luca, et al.
Publicado: (2020)

Synaptic Effects of Palmitoylethanolamide in Neurodegenerative Disorders
por: Assogna, Martina, et al.
Publicado: (2022)

Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration
por: Pellegrini, Carolina, et al.
Publicado: (2016)

Exploring the Role of Lipid-Binding Proteins and Oxidative Stress in Neurodegenerative Disorders: A Focus on the Neuroprotective Effects of Nutraceutical Supplementation and Physical Exercise
por: Scarfò, Giorgia, et al.
Publicado: (2022)

Palmitoylethanolamide shows limited efficacy in controlling cerebral cryptococcosis in vivo
por: Munzen, Melissa E., et al.
Publicado: (2023)

Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2014)

Possible Anandamide and Palmitoylethanolamide involvement in human stroke
por: Naccarato, Marcello, et al.
Publicado: (2010)

Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy
por: Gabrielsson, Linda, et al.
Publicado: (2016)

Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats
por: Seol, Tai-Kyung, et al.
Publicado: (2017)

Palmitoylethanolamide in the Treatment of Failed Back Surgery Syndrome
por: Paladini, Antonella, et al.
Publicado: (2017)

Palmitoylethanolamide: Prenatal Developmental Toxicity Study in Rats
por: Deshmukh, Narendra S., et al.
Publicado: (2021)

Palmitoylethanolamide: A Natural Compound for Health Management
por: Clayton, Paul, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a4pv7rjt7pfqc8pa1hulmbtt6g